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Summary
Recent advances in imaging techniques along with more powerful in vitro and in vivo models of
receptor-mediated ligand transport are facilitating advances in our understanding of how cells
efficiently direct receptors and their cargo to target destinations within the cytoplasm and at the
plasma membrane. Specifically, light and 3D electron microscopy studies to examine the trafficking
behavior of the neonatal Fc receptor (FcRn), a transport receptor for immunoglobulin G (IgG), have
given us new insights into the dynamic interplay between structural components of the cytosolic
trafficking machinery, its protein regulators, and the receptors it directs to various locations within
the cell. These studies build upon previous biochemical characterizations of FcRn transport and are
allowing us to begin formulation of a more complete model for the intracellular trafficking of
receptor-ligand complexes.
Introduction
Immunoglobulins are transported across epithelial cell barriers by specialized Fc receptors as
a part of adaptive immune processes. Over the past several decades, experiments using these
Fc receptors as model systems have greatly improved our understanding not only of receptor-
mediated ligand transport, but also of general mechanisms for intracellular protein trafficking.
One such Fc receptor, the neonatal Fc receptor (FcRn), mediates the passive acquisition of
humoral immunity in early pre- or post-natal mammals by transferring maternal
immunoglobulin G (IgG) to the fetus or suckling newborn [1–3]. In addition, FcRn serves to
extend the serum half-life of IgG in adult mammals by protecting it from a default degradative
pathway in vascular endothelial cells [4,5] and hematopoetic cell types [6,7]. While the ability
of FcRn to recycle and transcytose IgG bidirectionally in non-polarized and polarized and cell
models has been well documented [8–11], the specific mechanism(s) by which endocytosed
IgG is sorted from other vesicular cargo and directed through a progression of endosomal
compartments ultimately leading to the plasma membrane for fusion and exocytosis have been
poorly understood. Recent advances in techniques for the visualization of FcRn and FcRn-
ligand complexes has allowed for new insights into the mechanisms that shape and regulate
the process of FcRn-mediated trafficking. A combination of light-, live-cell-, and electron
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microscopy (EM) experiments of recent interest will be described here. A deeper understanding
of how FcRn properly targets itself and its ligand to their proper target destinations within the
cells has broad implications in understanding the biology of FcRn and IgG transport and
regulation, as well as in our understanding of receptor trafficking as a whole, which underlies
a large number of vital cellular processes.
Polarized epithelial barriers and transcytosis
Epithelial cell barriers serve as a means for complex organisms to distinguish, both spatially
and functionally, between the external environment and the underlying tissue. Polarized
epithelial cells are joined to one another by a structured, oligomeric transmembrane protein
complex known as the tight junction (TJ) [12]. This structure confers the cell’s ability to
selectively allow the passage of materials—such as ions, small molecules, peptides, lipids, and
proteins—either by passive or active (receptor-mediated) transport mechanisms [13–15]. TJs
prevent the contents of the membranes above and below the junction from mixing, thus
allowing these respective membrane domains to maintain distinct protein and lipid
compositions. The two membrane faces created as a result of this physical separation are
referred to as the apical (Ap) surface, which faces the external surface of the mucosae or the
lumen of an organ, and the basolateral (BL) surface, which faces the serosal surface or
bloodstream [12] (Figure 1). The apical and basolateral surfaces of polarized cells are
connected to one another via a multivesicular transport pathway called transcytosis.
Transcytosis is mediated by transmembrane receptors that originate on either the apical or
basolateral cell surface and transport cargo to the opposite plasma membrane (Figure 1). This
process requires that receptor-bound cargo be internalized into the endosomal membrane
system and trafficked to its target destination as determined by motifs within the cytoplasmic
tail of the receptor (for review, see [16]).
The endosomes of a cell are membrane-bound compartments that serve as the staging ground
for intracellular trafficking and protein sorting [17] (Figure 1). The vast numbers of endosomes
within the cell are classified into different subpopulations that are associated with different
functions (e.g., recycling, transcytosis, or degradation), and that maintain their identities based
on unique combinations of traffic-regulating membrane proteins associated with them [18–
20]. Only after receptors and their bound cargo have entered endosomes can the processes of
receptor sorting and trafficking be performed through a series of interactions between the
receptor and the various membrane proteins, adaptor proteins, and cytoskeletal components
that comprise the intracellular trafficking machinery [16]. It is this step-wise progression
through the intracellular trafficking itinerary that allows for transport to be precisely regulated
by the cell.
FcRn-mediated transport of IgG during transcytosis and recycling
Adult mammals have the capacity to generate antibodies against environmental antigens that
are encountered during their lifetime. Alternatively, pre-formed antibodies from one individual
can be transferred to another and confer immediate immunity to the antigen. Because the
immune-rendered individual does not produce the antibodies themselves, this is refereed to as
passive immunity [21].
Passive acquisition of antibodies is particularly important in the case of rodents and several
other mammals whose young are unable to produce their own IgG for up to two weeks post-
natally [21], despite being exposed to the external environment during this time. To
compensate, these animals acquire passive immunity during early life via IgG transferred from
the mother. IgG-rich colostrum is ingested and passes through the intestine where it is
transferred across the polarized epithelial cell lining into the bloodstream. This transfer is
mediated by FcRn. FcRn is a heterodimeric type I transmembrane glycoprotein consisting of
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a membrane-bound heavy chain that is non-covalently associated with a light chain, β2-
microglobulin (β2m), which also binds to class I MHC heavy chains [1,22] (Figure 2). High-
resolution crystal structures of the ectodomains of human and rat FcRn, as well as a complex
structure of rat FcRn in complex with Fc have been obtained [23–26]. FcRn is structurally
similar to class I MHC molecules, although the counterpart of the MHC peptide-binding groove
is narrowed and non-functional in FcRn, and binding to Fc is mediated in a manner that bears
no resemblance to MHC interactions with T cell or other immune receptors.
FcRn binds to the Fc region of IgG (Figure 2) with nanomolar affinity at pH ≤ 6.0, but exhibits
no binding at the basic pH of blood (pH 7.4) [27]. This pH-dependent binding helps to promote
the efficient unidirectional transfer of IgG from the acidic environment of the intestinal lumen
to the bloodstream of the neonatal rodent. During gestation in humans and non-human primates
maternal IgG is transferred to the fetus via FcRn-mediated transcytosis across placental
syncitiotrophoblast cells to provide the fetus with immunity to antigens encountered by the
mother [28]. The discovery that FcRn is expressed in the human fetal small intestine [29]
suggests that maternal IgG in ingested amniotic fluid could also be delivered to the fetal
circulation by transport across intestinal epithelial cells, consistent with a common mechanism
for passive immunization of human and rodent offspring. Unlike rodents, humans and non-
human primates develop the capacity to produce serum IgG within weeks of birth, thus, while
pre-natal IgG transfer is likely needed to confer protection from environmental antigens during
the first few weeks of independent life, post-natal transfer of maternal IgG does not occur
[21,30].
FcRn also plays an integral role in maintaining high serum levels of IgG. It was hypothesized
in the 1950s that IgG has a long half-life relative to other serum proteins because it was
protected from degradation by a receptor [21,31]. It was later shown that FcRn serves as the
IgG protection receptor by rescuing IgG that has been passively internalized via pinocytosis
by vascular endothelial cells from a default catabolic pathway [32–34]. Similar to the
mechanism of materno-fetal transfer in during primate gestation, FcRn binds to pinocytosed
IgG in the acidic environment of the endosomes. However in this setting FcRn then recycles
the IgG back to the cell surface where the IgG can dissociate and re-enter the circulation (Figure
1).
Cellular regulators of FcRn trafficking
The cytoplasmic tail of all species of FcRn contains canonical motifs associated with
endocytosis and post-synthetic membrane targeting; a WXXφ motif (where φ is a bulky
hydrophobic amino acid), instead of the canonical YXXφ motif, and an acidic dileucine motif
(DXXXLL) [11] (Figure 3). These motifs are known from previous biochemical and structural
data to bind to specific subunits of the AP-2 clathrin adaptor complex; a key mediator of
clathrin-dependent endocytosis [35,36] and have also been shown to play key roles in the
transcytosis and basolateral targeting of rat FcRn [37].
One of the larger classes of traffic-regulating proteins is the Rab family of small GTPases.
These small (~ 25 kDa) proteins exist in either the inactive GDP-bound or the active GTP-
bound state (for reviews see [38,39]). Rab proteins are soluble cytoplasmic proteins that are
prenylated in a regulated fashion by the enzyme Rab geranylgeranyl transferase (RabGG
transferase), which in turn allows them to be inserted into endosomal membranes [40]. The
transient association of Rab proteins with endosomal membranes allows the recruitment of
other effector molecules that in turn regulate endosome targeting and fusion [28]. A
combination of recent studies using fluorescence microscopy [41] and EM [42] have shown
that FcRn is colocalized with endosomes positive for Rab4, Rab5, Rab7, Rab9, and Rab11.
Rab5 is a known marker for early endosomes, Rabs 7 and 9 are markers for late endosomes
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and lysosomes [43], and Rabs 4 and 11 are associated with recycling from sorting endosomes
[38,44]. Fluorescence microscopy studies of the interplay between human FcRn (hFcRn) and
Rabs 4 and 11 found that while FcRn is present in sorting endosomes that are Rab4-positive
and Rab11-positive, tubular carriers that emanate from these sorting endosomes are gradually
depleted of Rab4 such that only Rab11 is found on FcRn-positive tubules that fuse with the
plasma membrane [41]. Similar studies on late endosomal/lysosomal maturation showed that
hFcRn present in late endosomes of endothelial cells is transferred to lysosomes via tubular
extensions that transiently fuse with lysosomes, rather than through bulk transfer by means of
full fusion, and that late endosomes contain both Rab5 and Rab7, perhaps indicating that FcRn
within these compartments is committed to neither the recycling (Rab5-associated) nor
lysosomal (Rab7-associated) fate until the time of exit from these structures [45]. The idea that
certain sorting structures within the cell are functionally diverse has been supported by recent
evidence that FcRn in polarized MDCK cells exits from recycling endosomes to enter either
transcytotic or recycling pathways [46], and that Rab25 is required for the transcytotic pathway
whereas Rab11, though dispensable for transcytosis, is required for recycling to the basolateral
membrane only [46]. Taken together, these data suggest that while specific endosomal
subpopulations retain their identities by association with a unique combination of membrane-
bound regulator and/or effector molecules these associated proteins can facilitate the sorting
and transfer of receptor-ligand complexes with multiple fates from a single endosome or cluster
of “identical” endosomes. More recent evidence shows that the hFcRn cytoplasmic tail can
bind to the cytoplasmic regulatory protein calmodulin and that this interaction can be abrogated
by mutation of two conserved arginine residues in the membrane-proximal region of the
cytoplasmic tail (Figure 3) [47]. These mutations reduce both receptor stability (as determined
by pulse-chase labeling experiments) and transcytosis of the receptor in epithelial MDCK cells
[47]. Whether calmodulin binding represents a direct signal to recruit other effector molecules
to endosomes carrying FcRn and FcRn-IgG complexes or acts as a negative regulator by
masking interaction sites within the FcRn cytoplasmic tail remains unknown.
Light microscopy studies of FcRn-mediated recycling of IgG
Live-cell fluorescence microscopy had been used to examine events that occur during FcRn-
mediated recycling of human IgG (hIgG) in endothelial cells. For example, visualization of
FcRn-GFP transfected cells incubated with fluorescently-labeled wild-type hIgG and hIgG
bearing a mutation that disrupts binding to FcRn (H435A) showed that wild-type hIgG exited
spherical sorting endosomes in tubules that were FcRn-positive, whereas the non-FcRn-
binding H435A IgG mutant accumulated in spherical endosomes and was ultimately detected
in lysosomes [9], consistent with a model whereby FcRn salvages IgG by physically carrying
it along a recycling pathway that terminates at the plasma membrane rather than the default
degradative pathway that terminates in the lysosomes. Additionally, recombinant Fc proteins
that bear only one FcRn binding site have been shown to have significantly shorter serum
persistence in mice [48,49], and greater lysosomal accumulation in transfected Madin-Darby
canine kidney cells with concomitant reduction in their transcytotic and recycling efficiencies
[10] as compared to their wild-type counterparts with two FcRn binding sites, suggesting that
avidity effects conferring high apparent affinity to the FcRn-IgG interaction are necessary for
efficient recycling.
Recent work using advanced light microscopy techniques has allowed the visualization of FcRn
and FcRn-ligand complexes moving within and between different endosomal subpopulations
during intracellular trafficking. The release of FcRn-bound IgG from the recycling surface has
also been visualized using total-internal reflection microscopy (TIRFM) in which fluorophores
present in a narrow plane of the plasma membrane are excited with laser light (for review of
TIRFM, see [50]). In studies using this technique to visualize FcRn trafficking events leading
to exocytosis in living endothelial cells two types of events were observed; full-release events
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in which FcRn-bound IgG quickly and completely exited the membrane fusion site, and
“prolonged release” events in which IgG remained associated with the fused vesicle and was
released slowly over several minutes [51]. Combining TIRFM with conventional
epifluorescence imaging in one setup allows the simultaneous acquisition of more than one
focal plane (termed multifocal plane microscopy, or MUM) [52,53]. In MUM studies
examining the post-endocytotic fate of FcRn:IgG-containing vesicles, it was observed that two
types of endosomal fusion events occur after vesicles pinched off from the plasma-membrane;
“direct” fusion in which vesicles fused with the endosomal network immediately following
endocytosis, and “indirect” fusion in which newly internalized vesicles move about the
cytoplasm for a varied amount of time prior to endosomal fusion [54].
Electron tomography studies of FcRn-mediated transcytosis of IgG
Electron tomography is an EM technique used to obtain three-dimensional (3D) data from a
series of two-dimensional projection images [55–58]. A resolution of ~4 nm, at least two orders
of magnitude higher than conventional light microscopy, can often be attained from cellular
samples [55–58]. To visualize FcRn-mediated ligand transport within an in vivo setting, rat Fc
molecules were chemically coupled to 1.4 nm Nanogold clusters via the cysteine residues of
the Fc hinge, and gold-labeled Fc (Au-Fc) was fed to neonatal rats to allow FcRn-mediated
uptake of the labeled ligand in the intestine, mimicking the transfer of maternal IgG across the
intestine of the newborn [59,60]. Electron tomography performed on harvested intestinal
samples revealed a complex picture of entangled tubular and irregular Au-Fc-containing
endosomes in different regions of the cell [42] (Figure 4A,B). Most of the Fc-containing
vesicles, including multivesicular bodies (Figure 4A,B), were identified as early and/or
recycling vesicles in immunolabeling studies using antibodies against endosomal markers,
which revealed a plethora of morphologies for endosomes bearing early, recycling, and late
endosomal markers.
One of the more surprising observations from the electron tomography studies was the presence
of clathrin-coated vesicles containing Au-Fc that appeared to be fusing with the lateral plasma
membrane [42]. While clathrin is classically believed to be involved in endocytosis via coated
pits and some intracellular trafficking functions, its involvement in exocytosis had not
generally been considered a possibility because it was believed that the clathrin coats on
trafficking vesicles are shed prior to membrane fusion [61–63]. However, two lines of evidence
suggested that these clathrin-coated structures could not be endocytosing Au-Fc. First, the pH
in the lateral intracellular space (LIS) should not be permissive for FcRn binding, as this space
is contiguous with the circulation (pH 7.4). Second, the concentration of Au-Fc in the blood
of the rat should not be high enough to permit binding to FcRn and should furthermore be
competed away by the high concentration of unlabeled, endogenous IgG in the circulation. For
these reasons the authors hypothesized that clathrin-coated vesicles containing FcRn-ligand
complexes can partially uncoat and fuse with the target plasma membrane [42]. Subsequently,
the vesicle may fully uncoat, releasing the FcRn molecules into the target membrane and
allowing for its bound cargo to dissociate into the extracellular space. Alternatively, the
partially clathrin-coated vesicle may remain at the membrane, allowing diffusion of ligand
through the opening of the partially fused vesicle in a process akin to so-called “kiss-and-
run” [64] or “prolonged release” [51] before pinching back off and transporting the free receptor
back to the apical surface to acquire more ligand. The later model has the advantage of
conserving the energy that would be required to fully uncoat the vesicle (an ATP-dependent
process) and to reassemble the endocytic machinery required to return ligand-free FcRn back
to the apical surface for subsequent round of transcytosis.
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Conclusions
Taken together, recent light microscopy and EM studies of FcRn-mediated transport
demonstrate the dynamic interplay of multiple effector molecules required for proper
trafficking of FcRn-IgG complexes. They also raise new questions about the precise nature of
FcRn-effector interactions within the cytoplasm and whether these interactions are modulated
or altered when FcRn is bound or free of its IgG ligand. One immediate question posed by
these studies is how FcRn, one of many trafficking receptors within the cell, can precisely
navigate the complex endosomal network while carrying cargo to its proper target destinations.
By analogy, one can ask how a group of travelers on a busy freeway can determine which
vehicles will carry them to their destinations while navigating within and around other traffic
and travelers with the same requirement (Figure 4C). A comparison of the recent data from
light microscopy and EM tomography supports the notion that FcRn-IgG complexes can take
multiple routes to their target destinations and that trafficking, although precisely regulated by
signals from the receptor itself and the cytosolic trafficking machinery, may be a flexible and
forgiving process. This may not be surprising given the chaotic and highly dense environment
in which trafficking takes place – i.e., the cytoplasm.
While exciting advances in our understanding of FcRn trafficking and function have come in
recent years due to the development of new techniques to visualize FcRn-ligand complexes
during transport, a variety of questions remain. Significant progress is likely to be made in the
coming years by combining existing techniques while further developing them. Specifically,
studies which combine high resolution, yet static, data offered by EM tomography with the
dynamic, yet lower resolution, data from live-cell imaging experiments off great potential to
further our understanding of the intricate and pervasive process of receptor-mediated ligand
transport.
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Figure 1.
(A) Schematic diagram showing canonical transcytotic and recycling pathways in polarized
epithelial cells. Receptors (such as FcRn) at the cell surface bind their cognate ligands (such
as IgG) and are internalized into clathrin-coated pits (CCPs), which pinch off from the plasma
membrane to form clathrin-coated vescicles (CCVs). After uncoating these vesicles fuse with
the endosomal network and enter the sorting endosome (SE) from which they can follow
multiple routes including transcytosis via transcytotic vesicles (TCVs), return to the cell surface
via the recycling endosome (RE), or degradation by way of the late endosome (LE) and
lysosome (LYS). Lysosomal accumulation of IgG is most likely an off-pathway process that
occurs in the presence of excess IgG. TJ: Tight junction. Nu: Nucleus. (B) Cartoon depiction
of the “Freeway Problem”. Multiple travelers (receptor-ligand complexes) must navigate to
multiple target destinations by moving about a crowded freeway (the cytoplasm) in various
vehicles (endosomes). How the travelers are directed to the appropriate vehicles and
subsequently navigated to their destinations is akin to the problem of intracellular receptor
trafficking.
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Figure 2.
Ribbon diagram of the rat FcRn/Fc structure. FcRn forms a 2:1 complex with Fc and IgG
molecules (i.e., two FcRn molecules bind to a single homodimeric Fc). FcRn (a heterodimer
consisting of a heavy chain (blue) and β2-microglobulin (β2m; green) light chain) binds to Fc
(red) at the junction between the CH2 and CH3 domains. In this orientation, the Fab arms of
an intact IgG would project down from CH2 domains.
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Figure 3.
Alignment of the cytoplasmic tail regions from multiple species of FcRn. Conserved residues
are marked by gray boxes. Residues that have been experimentally demonstrated to effect
receptor transport or trafficking are marked by a double dagger. Regions that correspond to
canonical intracellular trafficking motifs are indicated on the bottom row.
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Figure 4.
Multiple pathways for FcRn-mediated transport observed by EM tomography. (A) Segmented
model from a 3D reconstruction of gold-labeled Fc (Au-Fc) in endosomes of a neonatal rat
intestinal cell (reproduced from Supplementary Figure S11b in [42]). Color coding for
structures: tubular and irregular vesicles (blue shades); microtubules (pink rods); lysosomes
(violet); rough endoplasmic reticulum (green with scarlet ribosomes); mitochondria (bright
green); lateral membranes between adjacent cells (purple and blue); clathrin coats (small red
spheres around blue vesicles/buds); Au-Fc (gold spheres). Note that groups of tubular and
irregular endosomes sometimes form entangled masses. Only a small number of these
endosomes are associated with microtubules, suggesting that these entangled networks may
move as a cohesive unit. (B) Schematic representation of observations from EM tomography
studies of Au-Fc transport across neonatal rat intestine by FcRn (adapted from Figure 5h in
[42]). Gold dots indicate the presence of Au-Fc in the observed structures. Red dashes indicate
the presence of clathrin coats. Pink rods are microtubules, which were often associated with
tubular endosomes containing Au-Fc. (C) Suggested solution to the “Freeway Problem”.
Travelers (receptor-ligand complexes) can take multiple routes to their target destinations, with
vehicles (endosomes) often moving in groups rather than as individual entities.
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